Two Arrested With Huge Quantity Of Narcotic Drugs

Ludhiana: While many youths hooked to drugs were losing lives in the state, peddlers continue to supply banned drugs and injections to youngsters. Cracking a whip against the smugglers, the police today arrested two suspects and a huge number of banned drugs and injections were recovered from them, which they were supposed to sell to the youths directly or through agents.

Kuldeep Singh, a resident of Deloana village in Mansa and at present residing in Jassian, here, and Deepak Sharma, a resident of Ashok Nagar, Ludhiana, were nabbed by the PAU police when the duo were going on a scooter (bearing registration no PB10 JJ 3767) with a large number of banned drugs and injections.

The PAU police have registered a case under Sections 22, 61and 85 of the NDPS against the duo. While there has been no case registered against Deepak Sharma in the past, a case was registered against Kuldeep at Rajpura, Patiala, for smuggling drugs.

Dr GS Grewal, a physician, said the seized drugs were habit-forming medicines, which could not be sold without prescription and chemists give the same only to buyers after taking their identity proof. Tramadol was basically a derivative of opium which was given to patients having extreme pain. These come under the category of banned drugs, which could not be taken without doctor’s consultation.

The drugs that were seized from the suspects include 7,200 capsules of Acetaminophen Tramadol HCL and Dicyclomine HCL, 2,000 Tradamol prolonged release capsules, 900 Pentazocine Lactate and Penta 900 injections, 6,600 tablets of Alprazolam and Alpcore, 750 injections of Tramadol hydrochloride injection and Brutram.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre